搜尋
Immunome Inc
IMNM添加自選
23.610USD
+2.120+9.87%
收盤 07/02, 13:00（美東）報價延遲15分鐘
2.67B總市值
虧損本益比TTM
股東統計
更新時間: 5月11日 週一
更新時間: 5月11日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Fidelity Management & Research Company LLC
14.60%
T. Rowe Price Investment Management, Inc.
11.85%
Point72 Asset Management, L.P.
6.21%
BlackRock Institutional Trust Company, N.A.
5.61%
Redmile Group, LLC
5.05%
其他
56.67%
持股股東
持股股東
佔比
Fidelity Management & Research Company LLC
14.60%
T. Rowe Price Investment Management, Inc.
11.85%
Point72 Asset Management, L.P.
6.21%
BlackRock Institutional Trust Company, N.A.
5.61%
Redmile Group, LLC
5.05%
其他
56.67%
股東類型
持股股東
佔比
Investment Advisor
56.69%
Investment Advisor/Hedge Fund
26.03%
Hedge Fund
14.33%
Corporation
6.00%
Research Firm
3.19%
Venture Capital
2.09%
Individual Investor
1.33%
Bank and Trust
0.37%
Pension Fund
0.18%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
380
116.25M
102.66%
+15.81M
2025Q4
349
92.88M
84.18%
+6.06M
2025Q3
328
84.54M
92.66%
-1.54M
2025Q2
326
85.20M
99.48%
+13.79M
2025Q1
320
89.38M
113.71%
+17.13M
2024Q4
278
64.18M
84.45%
+3.64M
2024Q3
252
62.39M
103.49%
+7.38M
2024Q2
228
58.25M
97.90%
+16.13M
2024Q1
182
46.83M
84.41%
+22.74M
2023Q4
113
32.29M
78.79%
+19.76M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Fidelity Management & Research Company LLC
16.54M
14.62%
+3.48M
+26.67%
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
13.42M
11.86%
+2.78M
+26.09%
Dec 31, 2025
Point72 Asset Management, L.P.
7.03M
6.22%
+2.21M
+45.82%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
6.35M
5.61%
+1.12M
+21.32%
Dec 31, 2025
Redmile Group, LLC
5.72M
5.05%
+695.00K
+13.84%
Dec 31, 2025
PRIMECAP Management Company
4.69M
4.14%
+1.67M
+55.25%
Dec 31, 2025
Enavate Sciences GP, LLC
4.77M
4.21%
--
--
Dec 31, 2025
State Street Investment Management (US)
3.87M
3.42%
+1.06M
+37.95%
Dec 31, 2025
Driehaus Capital Management, LLC
3.71M
3.28%
+3.01M
+432.05%
Dec 31, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Genomics Immunology and Healthcare ETF
2.62%
Tema Oncology ETF
1.97%
WisdomTree BioRevolution Fund
1.53%
Virtus LifeSci Biotech Clinical Trials ETF
1.11%
ALPS Medical Breakthroughs ETF
0.55%
State Street SPDR S&P Biotech ETF
0.34%
iShares Micro-Cap ETF
0.24%
Direxion Daily S&P Biotech Bull 3X Shares
0.21%
iShares Russell 2000 Growth ETF
0.07%
iShares US Tech Breakthrough Multisector ETF
0.06%
查看更多
iShares Genomics Immunology and Healthcare ETF
佔比2.62%
Tema Oncology ETF
佔比1.97%
WisdomTree BioRevolution Fund
佔比1.53%
Virtus LifeSci Biotech Clinical Trials ETF
佔比1.11%
ALPS Medical Breakthroughs ETF
佔比0.55%
State Street SPDR S&P Biotech ETF
佔比0.34%
iShares Micro-Cap ETF
佔比0.24%
Direxion Daily S&P Biotech Bull 3X Shares
佔比0.21%
iShares Russell 2000 Growth ETF
佔比0.07%
iShares US Tech Breakthrough Multisector ETF
佔比0.06%